1. Home
  2. BKTI vs HUMA Comparison

BKTI vs HUMA Comparison

Compare BKTI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BK Technologies Corporation

BKTI

BK Technologies Corporation

HOLD

Current Price

$83.74

Market Cap

326.9M

Sector

Technology

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.80

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKTI
HUMA
Founded
1997
2004
Country
United States
United States
Employees
N/A
184
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
326.9M
308.6M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
BKTI
HUMA
Price
$83.74
$0.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$74.00
$6.19
AVG Volume (30 Days)
37.6K
15.5M
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
52.89
N/A
EPS
0.69
N/A
Revenue
$74,094,000.00
N/A
Revenue This Year
$6.57
$444.16
Revenue Next Year
$15.00
$248.39
P/E Ratio
$119.27
N/A
Revenue Growth
45.42
N/A
52 Week Low
$36.17
$0.55
52 Week High
$104.55
$2.84

Technical Indicators

Market Signals
Indicator
BKTI
HUMA
Relative Strength Index (RSI) 54.77 40.47
Support Level $76.11 $0.60
Resistance Level $85.90 $1.28
Average True Range (ATR) 3.14 0.12
MACD 0.50 -0.06
Stochastic Oscillator 86.81 21.34

Price Performance

Historical Comparison
BKTI
HUMA

About BKTI BK Technologies Corporation

BK Technologies Corp is a holding company that, through BK Technologies, Inc., its operating subsidiary, provides public safety-grade communications products and services designed to make first responders safer and more efficient. All operating activities described herein are undertaken by its operating subsidiary. The Company has one reportable segment - Land Mobile Radio (LMR) Products and Solutions. The LMR segment provides radio devices that are hand-held (portable) or installed in vehicles (mobile) and operate on private radio systems that are P25 compliant. The Company derives revenue in North America and manages the business activities on a consolidated basis.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: